mpc-6827
Small moleculeexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2005 (NCT00394446)
Timeline
Indications
Mechanism of action
- TubulinDISRUPTING AGENT
Tubulin disrupting agent
Binds to the same (or nearby) sites on ß-tubulin as colchicine
- Tubulin beta-4B chain (TUBB4B) ↗
- Tubulin beta-1 chain (TUBB1) ↗
- Tubulin alpha-3C chain (TUBA3C) ↗
- Tubulin alpha-4A chain (TUBA4A) ↗
- Tubulin beta-3 chain (TUBB3) ↗
- Tubulin alpha-1A chain (TUBA1A) ↗
- Tubulin beta-4A chain (TUBB4A) ↗
- Tubulin beta-8 chain (TUBB8) ↗
- Tubulin beta chain (TUBB) ↗
- Tubulin alpha-1B chain (TUBA1B) ↗
- Tubulin alpha-1C chain (TUBA1C) ↗
- Tubulin alpha-3E chain (TUBA3E) ↗
- Tubulin beta-2A chain (TUBB2A) ↗
- Tubulin beta-2B chain (TUBB2B) ↗
- Tubulin beta-6 chain (TUBB6) ↗
Chemistry & pharmacology
Loading structure…
SMILES
COc1ccc(N(C)c2nc(C)nc3ccccc23)cc1- Mol. weight
- 279.34 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL492399 ↗
Also known as
- mpc6827
- mpc-6827
- mpc-6827
- mpc-6827
- mpc-6827
- mx-128495
- mx-128495
- n-(4-methoxyphenyl)-n,2-dimethylquinazolin-4-amine
- verubulin
- verubulin
- verubulin
- verubulin
- verubulin hydrochloride
- verubulin hydrochloride
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01285414 | Phase 2 | Dec 1, 2010 | Myrexis Inc. |
| NCT00609011 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2008 | Myrexis Inc. |
| NCT00635557 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2008 | Myrexis Inc. |
| NCT00393965 | Phase 1 | Dec 1, 2005 | Myrexis Inc. |
| NCT00394446 | Phase 1 | Mar 1, 2005 | Myrexis Inc. |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Myrexis Inc. | For profit | 5 | 5 | 2 | 2005 |
1 organizations
Page 1 / 1